pamidronate disodium (pamidronate disodium Hexal) 15 mg/5 mL concentrated injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
01-12-2017

Bahan aktif:

pamidronate disodium, Quantity: 15 mg

Boleh didapati daripada:

Sandoz Pty Ltd

INN (Nama Antarabangsa):

pamidronate disodium

Borang farmaseutikal:

Injection, concentrated

Komposisi:

Excipient Ingredients: water for injections; sodium hydroxide; mannitol; phosphoric acid

Laluan pentadbiran:

Intravenous

Unit dalam pakej:

4, 1

Kelas:

Medicine Registered

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastases from breast cancer and advanced multiple myeloma; acute management of tumour-induced hypercalcaemia (Hypercalcaemia of malignancy); treatment of symptomatic Paget's disease of bone.

Ringkasan produk:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Status kebenaran:

Registered

Tarikh kebenaran:

2006-01-23